These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37790350)

  • 1. Impact of lesion location and functional parameters on vision-related quality of life in geographic atrophy secondary to AMD.
    Künzel SH; Broadbent E; Möller PT; Lindner M; Goerdt L; Czauderna J; Schmitz-Valckenberg S; Holz FG; Pfau M; Fleckenstein M
    medRxiv; 2023 Sep; ():. PubMed ID: 37790350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Lesion Location and Functional Parameters with Vision-Related Quality of Life in Geographic Atrophy Secondary to Age-related Macular Degeneration.
    Künzel SH; Broadbent E; Möller PT; Lindner M; Goerdt L; Czauderna J; Schmitz-Valckenberg S; Holz FG; Pfau M; Fleckenstein M
    Ophthalmol Retina; 2024 Aug; 8(8):794-803. PubMed ID: 38311207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the topographic location of geographic atrophy on vision-related quality of life in nonexudative age-related macular degeneration.
    Ahluwalia A; Shen LL; Bao Y; Sun M; Young BK; Park MM; Del Priore LV
    Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):699-708. PubMed ID: 36269402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Künzel SH; Möller PT; Lindner M; Goerdt L; Nadal J; Schmid M; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Pfau M
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):63. PubMed ID: 32462198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life.
    Ahluwalia A; Shen LL; Del Priore LV
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):307-316. PubMed ID: 32813108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural Biomarkers.
    Künzel SH; Lindner M; Sassen J; Möller PT; Goerdt L; Schmid M; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Pfau M
    JAMA Ophthalmol; 2021 Nov; 139(11):1191-1199. PubMed ID: 34591067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-luminance visual acuity and microperimetry in age-related macular degeneration.
    Wu Z; Ayton LN; Guymer RH; Luu CD
    Ophthalmology; 2014 Aug; 121(8):1612-9. PubMed ID: 24661863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-related quality of life is selectively affected by comorbidities in patients with geographic atrophy.
    Holm DL; Nielsen MK; Højsted BB; Sørensen TL
    BMC Ophthalmol; 2023 Apr; 23(1):153. PubMed ID: 37041490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast sensitivity and binocular reading speed best correlating with near distance vision-related quality of life in bilateral nAMD.
    Rossouw P; Guichard MM; Hatz K
    Ophthalmic Physiol Opt; 2020 Nov; 40(6):760-769. PubMed ID: 32959926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes.
    Burguera-Giménez N; García-Lázaro S; España-Gregori E; Gallego-Pinazo R; Burguera-Giménez N; Rodríguez-Vallejo M; Jonna G
    Clin Ophthalmol; 2020; 14():1533-1545. PubMed ID: 32669830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese Version of the Vision-Related Quality of Life (NEI-VFQ-25) among Patients with Various Ocular Disorders: A Pilot Study.
    Lee JS; Lin KK; Hou CH; Li PR; See LC
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS; Allingham MJ; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Fundus Autofluorescence and Near Infrared Reflectance as Prognostic Biomarkers for Visual Acuity in Foveal-Sparing Geographic Atrophy.
    Lindner M; Nadal J; Mauschitz MM; Lüning A; Czauderna J; Pfau M; Schmitz-Valckenberg S; Holz FG; Schmid M; Fleckenstein M
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO61-BIO67. PubMed ID: 28475704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice.
    Wang LL; Liu WJ; Liu HY; Xu X
    Chin Med J (Engl); 2015 May; 128(9):1154-9. PubMed ID: 25947396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.
    Sunness JS; Rubin GS; Broman A; Applegate CA; Bressler NM; Hawkins BS
    Ophthalmology; 2008 Sep; 115(9):1480-8, 1488.e1-2. PubMed ID: 18486216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning.
    Balaskas K; Glinton S; Keenan TDL; Faes L; Liefers B; Zhang G; Pontikos N; Struyven R; Wagner SK; McKeown A; Patel PJ; Keane PA; Fu DJ
    Sci Rep; 2022 Sep; 12(1):15565. PubMed ID: 36114218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS; Pieramici D; Chakravarthy U; Patel SS; Gupta S; Lotery A; Lad EM; Silverman D; Henry EC; Anderesi M; Tschosik EA; Gray S; Ferrara D; Guymer R;
    Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Comprehensive Vision Rehabilitation Using Vision-related Quality of Life Questionnaires: Impact of Vision Impairment and National Eye Institute Visual Functioning Questionnaire.
    Selivanova A; Fenwick E; Man R; Seiple W; Jackson ML
    Optom Vis Sci; 2019 Feb; 96(2):87-94. PubMed ID: 30589760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.